Ftse Mib
34.429,44
-0,09%
DAX
18.658,75
-0,13%
S&P 500
5.309,77
0,05%
NASDAQ
16.884,18
0,49%
Bitcoin
67.979,99
-1,63%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CollPlant Biotechnologies Ltd (CLGN) CollPlant Biotechnologies Ltd (CLGN) Notizie

CLGN

CollPlant Biotechnologies (CLGN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CLGN
DataOraFonteTitoloSimboloCompagnia
04/04/202413:31IH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:CLGNCollPlant Biotechnologies Ltd
15/02/202414:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
15/02/202414:00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
25/01/202421:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLGNCollPlant Biotechnologies Ltd
22/09/202313:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
26/06/202313:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
14/06/202313:34Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CLGNCollPlant Biotechnologies Ltd
18/04/202322:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202314:26Business WireStratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/03/202313:50Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CLGNCollPlant Biotechnologies Ltd
30/01/202320:54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLGNCollPlant Biotechnologies Ltd
13/01/202312:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLGNCollPlant Biotechnologies Ltd
06/01/202322:31Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/01/202313:00PR Newswire (US)CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of ObjectivesNASDAQ:CLGNCollPlant Biotechnologies Ltd
03/01/202313:00PR Newswire (US)CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder FormNASDAQ:CLGNCollPlant Biotechnologies Ltd
30/12/202222:32Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:CLGNCollPlant Biotechnologies Ltd
01/12/202213:00PR Newswire (US)CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial ResultsNASDAQ:CLGNCollPlant Biotechnologies Ltd
15/11/202213:00PR Newswire (US)CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative ColitisNASDAQ:CLGNCollPlant Biotechnologies Ltd
07/11/202213:00PR Newswire (US)CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90NASDAQ:CLGNCollPlant Biotechnologies Ltd
03/11/202212:00PR Newswire (US)CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17NASDAQ:CLGNCollPlant Biotechnologies Ltd
03/10/202213:00PR Newswire (US)CollPlant to present at the Dawson James Small Cap Growth Conference on October 12NASDAQ:CLGNCollPlant Biotechnologies Ltd
19/09/202213:00PR Newswire (US)CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, ItalyNASDAQ:CLGNCollPlant Biotechnologies Ltd
06/09/202213:00PR Newswire (US)CollPlant Biotechnologies to Participate in September Investor ConferencesNASDAQ:CLGNCollPlant Biotechnologies Ltd
25/08/202213:00PR Newswire (US)CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial ResultsNASDAQ:CLGNCollPlant Biotechnologies Ltd
05/07/202213:00PR Newswire (US)CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, CanadaNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/06/202214:45PR Newswire (US)CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine StudyNASDAQ:CLGNCollPlant Biotechnologies Ltd
20/06/202211:01TipRanksAnalysts Are Bullish on These Healthcare Stocks: Collplant Holdings (CLGN)NASDAQ:CLGNCollPlant Biotechnologies Ltd
26/05/202213:00PR Newswire (US)CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial ResultsNASDAQ:CLGNCollPlant Biotechnologies Ltd
25/04/202213:00PR Newswire (US)CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and ScreeningNASDAQ:CLGNCollPlant Biotechnologies Ltd
13/04/202213:00PR Newswire (US)CollPlant To Present at the Aesthetics Innovation Summit 2022NASDAQ:CLGNCollPlant Biotechnologies Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CLGN

La tua Cronologia

BIT
P1WQ97
NLBNPIT1WQ97 20240620 14...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network